Matches in Nanopublications for { ?s ?p "[TLR4 ligand (LPS) and H?O? cooperated with TGF-?1 to enhance the sustained activation of non-Smad pathways, including p38MAPK, ERK, JNK, PI3K, and NF-?B.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 7 of
7
with 100 items per page.
- NP477157.RACUiRuwtC1UkJDJ0T7GiojgEvJngj359dIQ5MRx9YB8s130_assertion description "[TLR4 ligand (LPS) and H?O? cooperated with TGF-?1 to enhance the sustained activation of non-Smad pathways, including p38MAPK, ERK, JNK, PI3K, and NF-?B.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP477157.RACUiRuwtC1UkJDJ0T7GiojgEvJngj359dIQ5MRx9YB8s130_provenance.
- NP895098.RAsGvtqLOpD_saSbWf_j--d1iedDRvGoBTRxSWyJ946Oc130_assertion description "[TLR4 ligand (LPS) and H?O? cooperated with TGF-?1 to enhance the sustained activation of non-Smad pathways, including p38MAPK, ERK, JNK, PI3K, and NF-?B.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP895098.RAsGvtqLOpD_saSbWf_j--d1iedDRvGoBTRxSWyJ946Oc130_provenance.
- NP192391.RAstbGHLcQ5ZYdGP6KEr8c9BYMn1WzKzUR042YtEJ7U6A130_assertion description "[TLR4 ligand (LPS) and H?O? cooperated with TGF-?1 to enhance the sustained activation of non-Smad pathways, including p38MAPK, ERK, JNK, PI3K, and NF-?B.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP192391.RAstbGHLcQ5ZYdGP6KEr8c9BYMn1WzKzUR042YtEJ7U6A130_provenance.
- NP505519.RAdtOHQWThMtGppOfAckiwGOMPnrCB6Zhdvla7f2mJZRA130_assertion description "[TLR4 ligand (LPS) and H?O? cooperated with TGF-?1 to enhance the sustained activation of non-Smad pathways, including p38MAPK, ERK, JNK, PI3K, and NF-?B.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP505519.RAdtOHQWThMtGppOfAckiwGOMPnrCB6Zhdvla7f2mJZRA130_provenance.
- NP446842.RAE2E4C3KvpcY2uPfxB3JpHyoJ5m-UXm8HQl72SPLLa6o130_assertion description "[TLR4 ligand (LPS) and H?O? cooperated with TGF-?1 to enhance the sustained activation of non-Smad pathways, including p38MAPK, ERK, JNK, PI3K, and NF-?B.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP446842.RAE2E4C3KvpcY2uPfxB3JpHyoJ5m-UXm8HQl72SPLLa6o130_provenance.
- NP666734.RAEuNviLA9TEm4BmXThUEigl_GuCtTh7nFIpn4fs89NM0130_assertion description "[TLR4 ligand (LPS) and H?O? cooperated with TGF-?1 to enhance the sustained activation of non-Smad pathways, including p38MAPK, ERK, JNK, PI3K, and NF-?B.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP666734.RAEuNviLA9TEm4BmXThUEigl_GuCtTh7nFIpn4fs89NM0130_provenance.
- NP764903.RAJX3ObF4v6xqehMNAHUze_G8HxJtovcN-gV5I6000ogc130_assertion description "[TLR4 ligand (LPS) and H?O? cooperated with TGF-?1 to enhance the sustained activation of non-Smad pathways, including p38MAPK, ERK, JNK, PI3K, and NF-?B.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP764903.RAJX3ObF4v6xqehMNAHUze_G8HxJtovcN-gV5I6000ogc130_provenance.